ArticleClinical and translational medicine2022

HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progression.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.